Gary Gensler, an American public official and professor of economics who has made pro-Bitcoin comments in the past, has now found himself tapped to lead the transition team for financial policy under President Elect Joe Biden.
Investors should be preparing for life under the new Biden administration, and that means looking for big themes, and for industries and individual companies that can benefit from them over the next four years.
Former Vice President Joe Biden will be the 46th president of the United States; with that comes an array of investment implications, perhaps none more profound than what's being reflected in the renewable energy sector.
Can the consumer, which has been the driving force of the U.S. economic recovery, remain resilient amid the recent rise in Covid cases? This question, among others, will be answered, by Walmart (WMT) when the retail giant reports third quarter fiscal 2021 earnings.
Baidu’s strong balance sheet, which compares favorably to its American tech counterparts such as Google (GOOG, GOOGL), is now being applauded. But can the excitement continue?
News from Moderna (MRNA) showed that its COVID-19 vaccine was more than 94% effective; this will likely continue the sector rotation that began last week that pressured work from home stocks. Rising case counts also pose as a headwind to the coming quarters.
There are a lot of moving parts when tackling these three different domains and I want to share with you the pillars I utilize that serve as the backbone for the processes within my firm.
During a recent webinar with the Thirty Percent Coalition, Nasdaq President and Chief Executive Officer Adena Friedman spoke about the importance of diversity in the boardroom and the role exchanges play in advancing diversity.
Normally we would say the weekend can’t come soon enough but given the prospects for another step up in virus case counts, lockdowns, and restrictions, this is one weekend we’re not rushing to get to.
One of the things that has struck me as the pharma industry has come up with a response to Covid-19 is just how mainstream the once niche area of biotech has become, and how dependent we have become on what are known as “large molecule” therapies.
When they realized that many of their own friends did not grasp investing basics, Rapunzl co-founders Myles Gage and Brian Curcio saw an enormous opportunity. By leveraging data-driven technology, they knew they could make investing accessible to a new generation of investors.